Revenue: The sum of all revenue fields included for a company's operating activities.
Acrivon Therapeutics, Inc. (ACRV) Revenue data is not available.
Income Statement Financials | |
Revenue |
-- |
$-80.56M |
|
-- |
|
-- |
|
$89.20M |
|
$-89.20M |
|
$8.64M |
|
$-80.56M |
|
$-80.56M |
|
$-80.56M |
|
$-80.56M |
|
$-80.56M |
|
$-80.56M |
|
$-89.20M |
|
$-91.97M |
|
33.79M |
|
33.79M |
|
$-2.38 |
|
$-2.38 |
|
Balance Sheet Financials | |
$181.63M |
|
$4.47M |
|
$14.96M |
|
$196.59M |
|
$17.21M |
|
-- |
|
$2.59M |
|
$19.80M |
|
$176.79M |
|
$176.79M |
|
$176.79M |
|
31.23M |
|
Cash Flow Statement Financials | |
$-65.67M |
|
$-51.77M |
|
$121.03M |
|
$36.43M |
|
$40.02M |
|
$3.59M |
|
$14.29M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
10.55 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-68.44M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-45.57% |
|
-45.57% |
|
-40.98% |
|
-45.57% |
|
$5.66 |
|
$-2.03 |
|
$-1.94 |